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ther elucidate the phenotypes related to the aberrations of 
the specific chromosome segments observed and underline 
the important role of low-level mosaics in the pathogenesis 
of NDDs of unknown etiology even in the absence of clinical 
signs of mosaicism.  © 2017 S. Karger AG, Basel 
 Chromosomal mosaicism is defined as the presence of 
2 or more chromosomally distinct cell lines in one indi-
vidual. Mosaics are often difficult to detect due to reasons 
such as subtle phenotypic abnormalities, technical limita-
tions, and tissue specificity. Advances in chromosomal 
microarray analysis (CMA) have made this method a 
powerful genome-wide analysis tool able to detect a wide 
range of aberrations, including mosaics of low level [Bal-
lif et al., 2006; Cheung et al., 2007; Pham et al., 2014]. It is 
well-known that the standard analysis of 15 cells obtained 
by traditional cytogenetics only provides a diagnostic ac-
curacy of  ≥ 20% for mosaicism of an entire chromosome 
[Hook, 1977]. Detection limits of CMA have been deter-
mined at 5% for whole chromosomes and 20% for seg-
mental mosaics [Ballif et al., 2006; Conlin et al., 2010; 
Scott et al., 2010; Hoang et al., 2011]. It has been suggest-
ed that for the detection of segmental low-level mosaics 
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 Abstract 
 Chromosomal mosaicism, which represents a diagnostic 
challenge for detection and interpretation, has been de-
scribed in several genetic conditions. It can contribute to a 
large phenotypic variation in diseases. At analysis of a well-
characterized cohort of 714 patients with neurodevelop-
mental disorders (NDDs) of unknown etiology using a high-
resolution chromosomal microarray platform, we found 2 
cases (0.28%) of low-level mosaicism and defined a previ-
ously detected extra chromosome in a third patient. Two of 
the cases were mosaics for segmental imbalances (a partial 
trisomy 3q26.1q27.3 and a partial monosomy 18q21.2qter 
with 14.6 and 20% mosaic ratios in lymphocytes, respective-
ly), and 1 was a mosaic for an entire chromosome (trisomy 
14, mosaic ratio 20%). Our diagnostic yield is in line with the 
ratios previously published in patients with intellectual dis-
ability. Notably, the partial trisomy 3q26.1q27.3 case is an 
example of a rare and unusual class of a rearranged neocen-
tric ring chromosome, which can neither be categorized in 
class I, nor in class II of such rearrangements. Our cases fur-
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(<10%), CMA coupled with conventional chromosome 
studies on more than 15 cells should be performed [Bi et 
al., 2013].
 In this work, we report on our results concerning chro-
mosomal mosaicism obtained in a cohort of 714 patients 
with a wide range of isolated or syndromic neurodevel-
opmental disorders (NDDs) and their phenotypical de-
scription.
 Patients and Methods 
 Patient Cohort 
 The cohort was previously reported [Asadollahi et al., 2014]. 
Briefly, excluding patients with large-scale chromosomal aberra-
tions (copy number variants >10 Mb) or clinically recognized re-
current microaberration syndromes, we investigated 714 patients 
with NDDs with or without further congenital anomalies by CMA 
analysis during a period of 3 years.
 Extraction of DNA 
 DNA extraction was performed from peripheral blood using a 
chemagen-automated device according to the manufacturer’s in-
struction (Perkin Elmer, Baesweiler, Germany).
 Microarray Analysis 
 DNA was analyzed with Affymetrix Genome-Wide Human 
SNP Array 6.0 (1.8 million markers; 79 patients), Affymetrix Cy-
togenetics 2.7 (2.7 million markers; 423 patients), or CytoScan HD 
(2.6 million markers; 212 patients; Affymetrix Inc., Santa Clara, 
CA, USA). Array hybridization was performed according to the 
manufacturer’s protocols. Data analysis was performed with the 
Chromosome Analysis Suite (ChAS) software (Affymetrix). For 
the mosaic analysis, no filter was applied.
 Fluorescence in situ Hybridization 
 Fluorescence in situ hybridization (FISH) analyses were per-
formed on metaphase preparations or on interphase nuclei using 
commercial BAC probes (Illumina, San Diego, CA, USA) accord-
ing to standard protocols. An α-satellite DNA probe specific for all 
human centromeres (Kreatech, Amsterdam, Netherlands) and an 
α-satellite chromosome 3-specific probe (Cytocell, Cambridge, 
UK) were used to characterize the neocentromere ring chromo-
some (NRC) 3.
 Results 
 Low-Level Mosaicism 
 In 3/714 individuals (0.4%), we detected a low-level 
mosaicism (CMA copy number state deviation <0.25). 
Two cases showed segmental mosaicism: 1 mosaic dupli-
cation of 19 Mb in 3q26.1q27.3 and 1 mosaic deletion of 
20.7 Mb in 18q21.2qter. The third case was a mosaic tri-
somy of the entire chromosome 14. All of these findings 
explained the respective patient’s phenotype. Informed 
consent for detailed publication of the phenotypes was 
obtained for the 2 cases with unusual segmental aberra-
tions, but not for the third case with a chromosome 14 
mosaic. For this reason, no clinical information and no 
description are given for the latter case.
 Case 1 (ID1392): Mosaic Duplication of 3q26.1q27.3 
in a Patient with Mild Intellectual Disability and 
Postaxial Polydactyly of the Hands 
 This patient was a 14-year-old boy with mild intellec-
tual disability (ID), bilateral postaxial polydactyly of the 
hands, and mild dysmorphic facial features. He was born 
after an uneventful pregnancy with normal growth mea-
surements (weight: 3,445 g, length: 48 cm). After birth, 
bilateral postaxial polydactyly of the hands, mild upslant-
ing palpebral fissures, and folding of the upper ear helices 
were noted. At the age of 6 months, he was able to sit. At 
the age of 18 months, he could walk with support, and a 
developmental assessment showed a mild global develop-
mental delay (DD) with a developmental quotient of 60 
in all domains (cognition, language, motor, and social). 
Fine motor problems and frequent toe walking occurred 
(improved by physiotherapy). He had also undergone 
surgery for inguinal hernia and cryptorchidism.
 At referral to our center at the age of 14 years for ge-
netic assessment, his weight, height, and head circumfer-
ence were 50.2 kg (57th centile), 154.9 cm (18th centile), 
and 56 cm (81st centile), respectively. Physical examina-
tion revealed a coarse face with full lips and a bulbous 
nasal tip, prominent incisors, a high palate, additional 
interphalangeal flexion creases on both small fingers, 
which also showed mild clinodactyly, scars from surgery 
of postaxial polydactyly in both hands, and relatively 
broad feet with big toes as well as bilateral mild 2–3 syn-
dactyly. He was at the onset of puberty with some axillary 
and genitalia hair growth. He attended a special needs 
school but was able to read and write. He showed no 
signs of mosaicism such as body asymmetry or pigmen-
tary changes. Standard karyotyping performed at the age 
of 1 year had revealed a small supernumerary marker 
chromosome (SMC) in 30 and 45% of the analyzed meta-
phases from cultivated lymphocytes and skin fibroblasts, 
respectively. The origin of the SMC at that time could not 
be identified, but was assumed to be extra material from 
chromosome 16 after microdissection and FISH map-
ping. CMA performed 13 years later using the Affyme-
trix 2.7 array on a new blood sample allowed the charac-
terization of the SMC and revealed a 19-Mb duplication 
of chromosome 3q26.1q27.3 (hg19, chr3: 167,268,921–
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186,249,954) in mosaic form (CMA copy number state: 
2.3), encompassing 151 genes in total ( Fig. 1 ). FISH anal-
ysis using the BAC probe RP11-436A20 specific for the 
region 3q26.33 and a whole chromosome 3 painting con-
firmed the finding of a SMC in 14.6% and in 50% of the 
analyzed metaphases from newly sampled cultivated 
lymphocytes and skin fibroblasts, respectively. Of note, 
FISH analysis using an alphoid probe specific for chro-
mosome 3 and one for all human centromeres resulted 
in no detectable signals on the marker chromosome, in-
dicating an analphoid SMC. On the other hand, since the 
mosaic ratio remained unchanged in fibroblasts and 
comparable in lymphocytes through the years as well as 
the fact that the subtelomeric sequences are missing, it is 
likely that this SMC represents an interesting example of 
NRC. The location of kinetochore formation, however, 
was not studied with immunofluorescence and antibod-
ies to centromere protein CENP. The NRC was absent in 
parental blood, and we therefore assume that it occurred 
de novo ,  although germinal mosaics cannot be excluded.
 Case 2 (ID64988): Mosaic Deletion of 18q21.2qter in a 
Patient with DD and Atresia of the Auditory Canal 
 This patient was born after an uneventful pregnancy 
by emergency cesarean section because of breech presen-
tation. Birth growth measurements were normal, but he 
was hypotonic and exhibited feeding problems. After 
birth, atresia of the right external auditory canal with a 
preauricular tag and, subsequently, at the age of 6 months, 
a bilateral hearing impairment was diagnosed. He was 
able to sit at age 8.5 months and walk independently at 21 
months. He was referred for genetic assessment at the age 
of 2.5 years because of global DD, muscular hypotonia, 
mild facial dysmorphic features, and a bilateral hearing 
impairment. Weight, height, and head circumference 
were 13 kg (50th centile), 98 cm (97th centile), and 50 cm 
(25–50th centile), respectively. Physical examination re-
vealed a preauricular tag on the right side, long eye lashes, 
a broad mouth with everted lips, small fingers with broad 
short distal phalanges, bilateral clinodactyly of the fifth 
toes, tender translucent skin, fine hair, and cryptorchi-
dism on the right side. He showed no signs of mosaicism 
such as body asymmetry or pigmentary changes. He 
could climb stairs, but had dystonic movements. He had 
very limited speech with a vocabulary of about 5 words. 
Brain MRI at the age of 2 years showed delayed myelina-
tion. A broad developmental assessment at the age of 3 
years showed a severe global DD (developmental quo-
tient of 25) in all domains (cognition, language, and mo-
tor) and some autistic behaviors.
 CMA performed with the Affymetrix 2.7 array on 
blood revealed a 25.2-Mb deletion of chromosome 
18q21.2qter (hg19, chr18: 53,277,087–78,077,248) in mo-
saic form, encompassing 97 genes in total (CMA copy 
number state: 1.7; Fig. 2). FISH analysis confirmed the 
mosaic deletion in 20% of the cultivated lymphocytes 
(normal signals in 43 metaphases and 5 interphases, ab-
normal signals in 11 metaphases and 1 interphase) and in 
81% of the cells from a buccal swab.
BA
 Fig. 1. Mosaic duplication of 3q26.1q27.3 in a patient with mild 
intellectual disability and postaxial polydactyly of the hands.  A G-
banding of the 2 normal chromosomes 3 and the neocentric ring 
chromosome.  B Screenshot of microarray raw data. The arrow-
head indicates the smooth signal of markers, indicative of the in-
terstitial mosaic duplication in 3q26.1q27.3, slightly above 2. 
Chromosomal position and cytobands are given at the bottom. 
CMA copy number state: 2.3. 
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 Discussion 
 In a cohort of 714 cases with NDDs with or without 
further congenital anomalies, we detected chromosomal 
aberrations in 3 cases (0.4%). All of these mosaics were 
low level in lymphocytes, and 2 of them remained unde-
tected using classical cytogenetic techniques (mosaic tri-
somy 14 [not described in detail as mentioned above] 
and mosaic partial deletion on chromosome 18, i.e., case 
2). The third mosaic case, a small SMC, later identified as 
small NRC, was detected by conventional cytogenetics, 
but the precise identification of the material had been 
elusive until CMA analysis was performed. The inci-
dence we observed is in line with what has been previ-
ously reported (0.2–1%) in patients with ID [Ballif et al., 
2006; Cheung et al., 2007; Conlin et al., 2010; Bruno et 
al., 2011; Hoang et al., 2011]. Our findings underline the 
important role of low-level mosaics in the pathogenesis 
of NDDs of unknown etiology. In particular, a mosaic 
deletion of 18q in lymphocytes is a rare genetic abnor-
mality with a highly variable phenotype, which repre-
sents a diagnostic challenge for clinicians and underlines 
the importance of CMA testing in children with atresia 
of the auditory canal. This feature is indeed recurrent in 
the 18q22.3q23 deletion [Veltman et al., 2003], a syn-
drome that has been documented in more than 100 cases 
and occurs in approximately 1/40,000 live births [Cody 
et al., 1999, 2009]. Other common features include DD/
ID, short stature, hypotonia, craniofacial abnormalities, 
especially midface hypoplasia, hearing impairment, 
growth hormone deficiencies, abnormalities of the feet, 
and genital hypoplasia [Kline et al., 1993]. In 2007, a phe-
notypic map of chromosome 18 was created based on 
information from 29 patients defining critical regions
for microcephaly (region 18q21.33), short stature 
(18q12.1q12.3, 18q21.1q21.33, and 18q22.3q23), white 
matter disorders (18q22.3q23), growth hormone insuf-
ficiency (18q22.3q23), congenital aural atresia (18q22.3), 
and cognitive delay [Feenstra et al., 2007]. While mild ID 
was usually identified with deletions distal to 18q21.33, 
severe ID was usually observed with deletions proximal 
to 18q21.31 [Feenstra et al., 2007]. Similar to other re-
ported patients with larger terminal 18q deletions, our 
patient suffers from severe DD, hypotonia and cryptor-
chidism, but has neither short stature, nor microcephaly. 
He shows a very distinct wide hypotonic mouth. Recent-
ly, a case of a mosaic deletion resembling the one in our 
patient has been reported in the literature. The patient 
exhibited polydactyly of the feet, hypospadia, cardiovas-
cular abnormalities, and eye anomalies, such as bilateral 
microcornea with dense opacification and unilateral iris 
as well as chorioretinal coloboma [Galvin et al., 2015]. 
None of these features were present in our case. Of note, 
a broad phenotypic ocular spectrum was reported previ-
ously in 7 patients with deletion of the regions 18q21.3qter 
or 18q22.2qter [Kline et al., 1993]. In general, it is as-
sumed that the size of the deletion correlates with the 
phenotype severity [Cody et al., 2009], but in this case, 
A B
 Fig. 2. Mosaic deletion of 18q21.2qter in a patient with develop-
mental delay and atresia of auditory canal.  A Photograph of the 
patient at the age of 2½ years. Note the broad forehead, hyper-
telorism, flat nasal root, epicanthal folds, upturned nares, and 
everted lips.  B Screenshot of microarray raw data. The arrowhead 
indicates the smooth signal of markers, indicative of the mosaic 
terminal on chromosome 18, slightly below 2. Chromosomal posi-
tion and cytobands are given at the bottom. CMA copy number 
state: 1.7. 
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the mosaic ratio of aberrant cells and their localization 
may as well play a role.
 SMCs without detectable alphoid DNA represent a 
rare class of rearranged marker chromosomes. They oc-
cur with an incidence of 0.14–0.72/1,000 newborns and 
are not easily identifiable by G-banding or by FISH 
[Nielsen and Wohlert, 1991]. SMCs are referred to as 
neocentric marker chromosomes or NRCs, when an ec-
topic centromere is able to assemble a functional kineto-
chore that originates occasionally from non-centromeric 
regions of the chromosome, which rescues the chromo-
some fragments and restores their ability to segregate ef-
ficiently [Marshall et al., 2008].
 To date, more than 100 neocentromeres have been 
characterized in humans [Marshall et al., 2008; Alonso et 
al., 2010; Klein et al., 2012], and they show remarkable 
diversity in chromosome position and DNA sequences 
[Burrack and Berman, 2012].
 The formation of a neocentromere is generally associ-
ated with a chromosomal rearrangement, such as an in-
verted duplication of a distal chromosome segment lead-
ing to partial tetrasomy (class I) or a balanced chromo-
somal rearrangement into linear and circular marker 
chromosomes after an interstitial deletion (class II/Mc-
Clintock mechanism). Class I rearrangements represent 
the most common mechanism for the formation of SMCs, 
and the majority of SMCs reported in the literature affects 
the distal part of chromosome 3q, which appears to have 
a high propensity for neocentromere formation [Mar-
shall et al., 2008]. The long arm of chromosome 3, such 
as 3q26.2 and 3q27.2, is indeed a hotspot, for which other 
neocentromeres have been reported. Interestingly, the 
evolution of chromosome 3 in primates has been studied, 
and it has been shown that the region 3q26 was a centro-
meric region in a common ancestor of the Old World 
monkeys (Cercopithecidae) approximately 25–40 MYA. 
This suggests the possibility of reactivation of longstand-
ing latent centromeres and that there is an inherent po-
tential of these regions to form centromeres [Ventura et 
al., 2004].
 The marker in our case of a chromosome 3-derived 
neocentromeric chromosome can neither be classified in 
class I, nor in class II rearrangements, since our patient 
has 2 normal copies of chromosome 3 and a small addi-
tional mitotically stable segment, leading to a partial tri-
somy 3q in mosaic. An unusual and similar type of neo-
centromeric formation has already been described for 
chromosome 1 in one case [Spiegel et al., 2003], but, to 
the best of our knowledge, it has never been reported for 
chromosome 3.
 Neocentromeric formation of the distal region 3q has 
been associated with hyper- or hypopigmentation, hypo-
tonia, preauricular pits, accessory nipples, DD, and sei-
zures. In one male with a marker chromosome 3q26.2qter, 
the postaxial polydactyly has been reported together with 
asymmetric cerebral ventricles, a duplicated right kidney, 
and right pulmonary artery stenosis [Teshima et al., 
2000]. An acentric marker chromosome involving the re-
gion 3q27 has also been reported in a young man with 
normal intelligence and hyperpigmentation, but no dys-
morphism [Portnoi et al., 1999]. Similar to the pheno-
typic features already described in the literature, our pa-
tient shows mild ID and postaxial polydactyly, but no ab-
normal skin pigmentation. The large variability of the 
clinical findings in patients with SMCs occurring in the 
distal region 3q is due to the different genetic content, 
type of rearrangement, tissue distribution, and the mo-
saic ratio.
 Of note, neither case 1 nor case 2 showed typical signs 
of chromosomal mosaicism such as body asymmetry or 
segmental pigmentary anomalies.
 In summary, identifying low-level mosaics remains a 
diagnostic challenge for cytogenetic and molecular test-
ing, and their detection is of utmost importance for an 
accurate etiological diagnosis and genetic counseling.
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